Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: A multimethod approach

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue 2, 2010, Pages 221-224

  Kunutsor, Setor ^a,d   Evans, Morgan ^a   Thoulass, Janine ^a   Walley, John ^a   Katabira, Elly ^b   Newell, James N ^a   Muchuro, Simon ^a   Balidawa, Hudson ^c   Namagala, Elizabeth ^c   Ikoona, Eric ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b MAKERERE UNIVERSITY   (Uganda)

^c Uganda National Aids Control Programme   (Uganda)

^d MALARIA CONSORTIUM   (United Kingdom)

Author keywords

Adherence measures; AIDS; Antiretroviral therapy; HIV; Optimal; Suboptimal

Indexed keywords

LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NEVIRAPINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CORRELATIONAL STUDY; FEMALE; GROUPS BY AGE; HEALTH CARE FACILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; TREATMENT DURATION; UGANDA; ADOLESCENT; AGE; CONFIDENCE INTERVAL; EPIDEMIOLOGY; HIV INFECTIONS; MEDICATION COMPLIANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-HIV AGENTS; CONFIDENCE INTERVALS; FEMALE; HIV INFECTIONS; HUMANS; LINEAR MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; QUESTIONNAIRES; UGANDA; YOUNG ADULT;

EID: 77957320030     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181e255ec     Document Type: Article

References (17)

1. UNAIDS. Report on the global AIDS epidemic 2008. Available at: http:// www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008- Global-report.asp. Accessed July 30, 2009
2. Stoneburner RL, Low-Beer D. Population-level HIV declines and behavioural risk avoidance in Uganda. Science. 2004;304:714-718.
3. WHO/UNAIDS/UNICEF Progress Report. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. June 2008. Available at: http://www.who.int/hiv/pub/2008progressreport/en/ index.html. Accessed September 12, 2009.
4. Vitolins MZ, Rand CS, Rapp SR, et al. Measuring adherence to behavioural and medical interventions. Control Clin Trials. 2000;21:S188-S194.
5. Laurent C, Diakhaté N, Fatou Ngom Gueye N, et al. The Senegalese government's highly active antiretroviral therapy initiative: An 18-month follow-up study. AIDS. 2002;6:1363-1370.
6. Byakika-Tusiime J, Oyugi J, TumwikirizeW, et al. Ability to purchase and secure stable therapy are significant predictors of non-adherence to antiretroviral therapy in Kampala, Uganda. Presented at: 10th Conference on Retroviruses and Opportunistic Infections; Boston, MA; 2003.
7. Orrell C, Bangsberg D, Badri M, et al. Adherence is not a barrier to delivery of HIV antiretroviral therapy in resource-poor countries. AIDS. 2003;17:1369-1375.
8. Oyugi J, Byakika-Tusiime JB, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36:1100-1102.
9. Wenger N, Gifford A, Liu H, et al. Patient characteristics and attitudes associated with antiretroviral (AR) adherence. In: Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, Virginia: Foundation for Retrovirology and Human Health; 1999. Abstract 98.
10. Montessori V, Heath KV, Yip B, et al. Predictors of adherence with triple combination antiretroviral therapy [abstract 72]. Presented at: 7th Conference on Retroviruses and Opportunistic Infections; 30 January to February 2, 2000; San Francisco, CA.
11. Gifford AL, Bormann JE, Shivley MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386-395.
12. Williams PL, Storm D, Montepiedra G, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006;118:1745-1757.
13. Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes RB, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979:49-62.
14. Uzochukwu BSC, Onwujekwe OE, Onoka AC, et al. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health Policy Plan. 2009;24:189-196.
15. Horne R. Adherence to medication, a review of existing research. In: Myers L, Midence K, eds. Adherence to Treatment in Medical Conditions. London, United Kingdom: Harwood Academic; 1998:285-310.
16. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral therapy who are lost to follow-up in Malawi. Bull World Health Organ. 220;85:550-554.
17. Weidle PJ, Wamai N, Solberg P, et al. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet. 2006; 368:1587-1594.